Myungmoon Phar (017180) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.006x

Based on the latest financial reports, Myungmoon Phar (017180) has a cash flow conversion efficiency ratio of -0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-664.77 Million ≈ $-450.51K USD) by net assets (₩103.67 Billion ≈ $70.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Myungmoon Phar - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Myungmoon Phar's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Myungmoon Phar total liabilities for a breakdown of total debt and financial obligations.

Myungmoon Phar Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Myungmoon Phar ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Prime Financial Group Ltd AU:PFG	0.036x
Steppe Cement F:ST9	0.046x
Mithril Silver and Gold Ltd AU:MTH	-0.013x
FAR Ltd AU:FAR	-0.008x
Industrial Investment Trust Limited NSE:IITL	0.148x
MoneyHero Limited Class A Ordinary Shares NASDAQ:MNY	-0.007x
Malayan United Industries Bhd KLSE:3891	0.379x
Mirae Asset Maps Reit 1 Co Ltd KO:357250	N/A

Annual Cash Flow Conversion Efficiency for Myungmoon Phar (2010–2024)

The table below shows the annual cash flow conversion efficiency of Myungmoon Phar from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Myungmoon Phar.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩103.12 Billion ≈ $69.88 Million	₩-1.34 Billion ≈ $-906.54K	-0.013x	+77.78%
2023-12-31	₩88.75 Billion ≈ $60.15 Million	₩-5.18 Billion ≈ $-3.51 Million	-0.058x	-201.57%
2022-12-31	₩95.27 Billion ≈ $64.56 Million	₩5.47 Billion ≈ $3.71 Million	0.057x	+477.20%
2021-12-31	₩85.87 Billion ≈ $58.20 Million	₩855.00 Million ≈ $579.42K	0.010x	+105.42%
2020-12-31	₩90.77 Billion ≈ $61.52 Million	₩-16.67 Billion ≈ $-11.30 Million	-0.184x	-400.89%
2019-12-31	₩80.20 Billion ≈ $54.35 Million	₩-2.94 Billion ≈ $-1.99 Million	-0.037x	-129.92%
2018-12-31	₩93.06 Billion ≈ $63.07 Million	₩11.41 Billion ≈ $7.73 Million	0.123x	+55.39%
2017-12-31	₩101.72 Billion ≈ $68.93 Million	₩8.02 Billion ≈ $5.44 Million	0.079x	+33.34%
2016-12-31	₩94.68 Billion ≈ $64.16 Million	₩5.60 Billion ≈ $3.80 Million	0.059x	+172.13%
2015-12-31	₩67.12 Billion ≈ $45.49 Million	₩-5.50 Billion ≈ $-3.73 Million	-0.082x	-16457.33%
2014-12-31	₩73.15 Billion ≈ $49.57 Million	₩-36.23 Million ≈ $-24.56K	0.000x	-101.81%
2013-12-31	₩73.20 Billion ≈ $49.60 Million	₩2.00 Billion ≈ $1.36 Million	0.027x	-28.27%
2012-12-31	₩72.87 Billion ≈ $49.38 Million	₩2.78 Billion ≈ $1.88 Million	0.038x	-10.77%
2010-12-31	₩67.13 Billion ≈ $45.49 Million	₩2.87 Billion ≈ $1.95 Million	0.043x	--

About Myungmoon Phar

KO:017180 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$40.51 Million

₩59.77 Billion KRW

Market Cap Rank

#22650 Global

#1545 in Korea

Share Price

₩1788.00

Change (1 day)

+0.00%

52-Week Range

₩1581.00 - ₩1945.00

All Time High

₩10277.86